Abbott FreeStyle Libre 3 App Recalled Over Sensor Signal Loss: Health Canada
Advertisement
Health Canada has classified a recall of the FreeStyle Libre 3 App as Type II. The notice covers several versions of the Android and iOS apps made by Abbott Diabetes Care Ltd. It was published on October 26, 2026 under identification number RA-82855, with a recall date of October 16, 2026.
Read Also
The recall follows a security update to the app. Abbott says the update was needed to keep the apps secure, but the fix introduced an unintended defect. Under certain conditions, the app can lose communication with the sensor for a prolonged period.
Products Affected by This Recall
The recall covers the FreeStyle Libre 3 App on both Android and iOS, model V3.4. The affected versions are listed below for each platform.
- FreeStyle Libre 3 App (Android): versions 3.6.4, 3.6.5, 3.6.6, 3.6.7 and 3.6.8
- FreeStyle Libre 3 App (iOS): versions 3.6.4, 3.6.5, 3.6.6, 3.6.7 and 3.6.8
No units, serial numbers or UPC codes are given in the notice. Identification depends on the app version installed on your phone.
Advertisement
Read Also
What Triggered the Recall
According to Abbott, the company identified an important security update for the app. That update was meant to address a sensor impersonation vulnerability, a weakness that could let something other than the real sensor pose as one.
The mitigation itself caused a new problem. Under certain conditions, it can result in a prolonged loss of communication between the mobile application and the sensor. Health Canada lists the issues as medical devices, device compatibility and medical devices, performance.
The notice does not describe any injuries or incidents. It also does not say how many users or how many installs are affected.
Who Should Be Concerned
Anyone in Canada using the FreeStyle Libre 3 App on an Android phone or an iPhone should check which version they have installed. Users on versions 3.6.4 through 3.6.8 are the ones named in the recall.
Because the problem involves the link between the app and the sensor, it matters most to people who depend on that connection throughout the day. The notice is aimed at the general public.
What Consumers Need to Do Now
Abbott advises customers to update the app right away to the latest version, 3.6.10, which is intended to rectify the issues. Here is a simple way to act on the notice:
- Open the app store on your phone (Google Play on Android or the App Store on iOS).
- Search for the FreeStyle Libre 3 App and check the installed version.
- If you are on version 3.6.4, 3.6.5, 3.6.6, 3.6.7 or 3.6.8, install the update to version 3.6.10.
- Confirm the app is communicating with your sensor after updating.
For further details on the recall, Health Canada refers consumers to the manufacturer’s website at HTTPS://WWW.LIBRECHECK.COM/EN-CA/HOME.HTML. If you have questions about how the app is working with your sensor, contact Abbott through that resource or speak with your health care provider.
Regulatory Response
Health Canada published the notice under its Recalls and safety alerts program, in the category of health products and medical devices for general hospital and personal use. The recall class is Type II.
The company named in the notice is Abbott Diabetes Care Ltd., Range Road, Witney, Oxfordshire, United Kingdom, OX29 0YL. The notice directs consumers to the manufacturer for details, and does not list a separate refund or replacement process.
Quick Facts
- Product: FreeStyle Libre 3 App (Android and iOS), model V3.4
- Affected versions: 3.6.4, 3.6.5, 3.6.6, 3.6.7, 3.6.8
- Fixed version: 3.6.10
- Recall date: 2026-10-16
- Recall class: Type II
- Recall number: RA-82855
- Published by: Health Canada
Consumers can sign up for email alerts from Health Canada to receive new and updated recall and safety notices. Health or safety concerns can also be reported through the Government of Canada’s online reporting service.
For now, the most important step is simple: check your app version and update it to 3.6.10 if you are on one of the affected versions.
Official Source: View original notice on Health Canada →
Advertisement